Nilesh Srivastav

Lecturer

Melbourne Institute, University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Nilesh Srivastav is a Lecturer at The University of Melbourne's Melbourne Institute in Australia. His research focuses on the safety and efficacy of COVID-19 vaccinations among autoimmune disease patients, as well as the long-term outcomes of various health conditions related to physical function. Recent publications include studies on vaccine safety, hesitancy, and the implications of COVID-19 on patients with idiopathic inflammatory myopathies and systemic sclerosis.

Articles (11)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

John D. Pauling

UNITED KINGDOM

View details

João Eurico Fonseca

PORTUGAL

View details

Rohit Aggarwal

University of Pittsburgh Medical Center

UNITED STATES

View details

Laura ANDREOLI

University of Brescia

ITALY

View details

Doa El-Ansary

Deputy Dean, Engagement and Head of Physiotherapy

RMIT University

AUSTRALIA

View details

Alistair Royse

University of Melbourne

AUSTRALIA

View details

Ioannis Parodis

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nilesh Srivastav

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

From a Position of Known Angiographic Perfect Patency: What Happens Next?

Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.

Long-Term Survival of Multiple Versus Single Arterial Coronary Bypass Grafting in Elderly Patients

Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.

Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys.

COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.

Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.

COVID-19 vaccination in autoimmune diseases (COVAD) Study: vaccine safety and tolerance in rheumatoid arthritis.

COVAD survey 2 long-term outcomes: unmet need and protocol

COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies

Coronary Artery Bypass Surgery Without Saphenous Vein Grafting

Collaborators (7)

John D. Pauling

João Eurico Fonseca

Rohit Aggarwal

Laura ANDREOLI

Doa El-Ansary

Alistair Royse

Ioannis Parodis

Make your next move.